Abstract
Detecting KRAS mutations in tumor samples can be challenging in low-middle-income countries due to limited access to molecular biology laboratories. The Idylla TM KRAS mutation test (IKMT) is an IVD, automated, and rapid qPCR assay to detect KRAS mutations, validated in colorectal cancer. We studied the concordance of the IKMT in KRAS mutation detection, compared with NGS, and performed a prospective KRAS mutation test feasibility study in samples from patients with NSCLC.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
